Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher
tabling member	label

Search

1149712

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:11:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:15:18 25/10/2019 12:26:02
	hansard heading	Fertility: Medical Treatments
	house id	2
	identifier	HL5
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 11:54:37
	question text	To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on the (1) Human Fertilisation and Embryology Act 2008, and (2) regulation of fertility treatment by the Human Fertilisation and Embryology Authority.
	session	2019/20
	session number	2
	tabling member printed	Baroness Barker
	title	House of Lords Tabled Parliamentary Question 2019/20 HL5
	type	WrittenParliamentaryQuestion
	uin	HL5
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2501 label Biography information for Baroness Barker
	publisher	25277
	tabling member	2501 label Biography information for Baroness Barker

1149713

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:11:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:15:21 25/10/2019 12:26:03
	hansard heading	Fertility: Medical Treatments
	house id	2
	identifier	HL6
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 11:54:37
	question text	To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on members of the trans community who wish to access fertility treatment at a licensed clinic.
	session	2019/20
	session number	2
	tabling member printed	Baroness Barker
	title	House of Lords Tabled Parliamentary Question 2019/20 HL6
	type	WrittenParliamentaryQuestion
	uin	HL6
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2501 label Biography information for Baroness Barker
	publisher	25277
	tabling member	2501 label Biography information for Baroness Barker

1149714

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:11:45
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:15:25 25/10/2019 12:27:05
	hansard heading	Mental Capacity: Codes of Practice
	house id	2
	identifier	HL7
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 11:55:05
	question text	To ask Her Majesty's Government when consultation on the Code of Practice issued under the Mental Capacity (Amendment) Act 2019 will commence.
	session	2019/20
	session number	2
	tabling member printed	Baroness Barker
	title	House of Lords Tabled Parliamentary Question 2019/20 HL7
	type	WrittenParliamentaryQuestion
	uin	HL7
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2501 label Biography information for Baroness Barker
	publisher	25277
	tabling member	2501 label Biography information for Baroness Barker

1149751

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:12:56
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:17:19 25/10/2019 12:38:06
	hansard heading	Vancomycin
	house id	2
	identifier	HL44
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 12:07:42
	question text	To ask Her Majesty's Government what information they hold on the availability of Vancomycin for the treatment of Clostridium difficile in pharmacies across the country.
	session	2019/20
	session number	2
	tabling member printed	Baroness Masham of Ilton
	title	House of Lords Tabled Parliamentary Question 2019/20 HL44
	type	WrittenParliamentaryQuestion
	uin	HL44
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	1850 label Biography information for Baroness Masham of Ilton
	publisher	25277
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1149756

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:25:12 25/10/2019 12:27:02
	hansard heading	Eating Disorders: Mental Health Services
	house id	2
	identifier	HL49
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 11:55:40
	question text	To ask Her Majesty's Government, following their response to the Seventeenth Report of Session 2017–19 by the House of Commons Public Administration and Constitutional Affairs Committee (HC855) on 23 September, how many sites have been selected to "pump prime" innovative models of service for adults with eating disorders; and where those test sites will be.
	session	2019/20
	session number	2
	tabling member printed	Baroness Parminter
	title	House of Lords Tabled Parliamentary Question 2019/20 HL49
	type	WrittenParliamentaryQuestion
	uin	HL49
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4178 label Biography information for Baroness Parminter
	publisher	25277
	tabling member	4178 label Biography information for Baroness Parminter

1149763

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:12
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:25:39 25/10/2019 12:38:08
	hansard heading	Health Services: British Nationals Abroad
	house id	2
	identifier	HL56
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 12:07:26
	question text	To ask Her Majesty's Government what steps they intend to take to ensure the provision of healthcare for UK pensioners living in the European Union post-Brexit.
	session	2019/20
	session number	2
	tabling member printed	Lord Taylor of Warwick
	title	House of Lords Tabled Parliamentary Question 2019/20 HL56
	type	WrittenParliamentaryQuestion
	uin	HL56
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	1796 label Biography information for Lord Taylor of Warwick
	publisher	25277
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1149773

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:26:52 25/10/2019 12:28:04
	hansard heading	Bevacizumab
	house id	2
	identifier	HL66
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 11:56:13
	question text	To ask Her Majesty's Government why Avastin is not routinely made available on the NHS for certain groups of cancer patients.
	session	2019/20
	session number	2
	tabling member printed	Lord Willis of Knaresborough
	title	House of Lords Tabled Parliamentary Question 2019/20 HL66
	type	WrittenParliamentaryQuestion
	uin	HL66
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4151 label Biography information for Lord Willis of Knaresborough
	publisher	25277
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1149774

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:26:55 25/10/2019 12:31:02
	hansard heading	Bevacizumab
	house id	2
	identifier	HL67
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 12:00:04
	question text	To ask Her Majesty's Government whether Avastin has approval from the European Medicines Authority to be used to treat cancer.
	session	2019/20
	session number	2
	tabling member printed	Lord Willis of Knaresborough
	title	House of Lords Tabled Parliamentary Question 2019/20 HL67
	type	WrittenParliamentaryQuestion
	uin	HL67
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4151 label Biography information for Lord Willis of Knaresborough
	publisher	25277
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1149775

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:32
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:26:58 25/10/2019 12:43:02
	hansard heading	Bevacizumab
	house id	2
	identifier	HL68
	legislature	25277
	parliament number	57
	question first answered	25/10/2019 12:11:29
	question text	To ask Her Majesty's Government whether there are (1) current applications, or (2) pending requests, for the use of Avastin following Phase 3 clinical trials.
	session	2019/20
	session number	2
	tabling member printed	Lord Willis of Knaresborough
	title	House of Lords Tabled Parliamentary Question 2019/20 HL68
	type	WrittenParliamentaryQuestion
	uin	HL68
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4151 label Biography information for Lord Willis of Knaresborough
	publisher	25277
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1149776

	human indexable
	published
	registered interest
	answer date	28/10/2019
	date	14/10/2019
	date tabled	14/10/2019
	ddp created	16/10/2019 15:13:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/10/2019 15:27:00 28/10/2019 13:30:08
	hansard heading	Bevacizumab
	house id	2
	identifier	HL69
	legislature	25277
	parliament number	57
	question first answered	28/10/2019 12:58:25
	question text	To ask Her Majesty's Government, if Avastin is approved for safe use, whether it could be privately purchased for use by a patient being treated on the NHS.
	session	2019/20
	session number	2
	tabling member printed	Lord Willis of Knaresborough
	title	House of Lords Tabled Parliamentary Question 2019/20 HL69
	type	WrittenParliamentaryQuestion
	uin	HL69
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4151 label Biography information for Lord Willis of Knaresborough
	publisher	25277
	tabling member	4151 label Biography information for Lord Willis of Knaresborough